Nanjing Pharma

BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.  (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…
0874.HK
600332.SHG
600713.SHG

Recent Articles

RELATED ARTICLES

  1. Baiyunshan supports stock price with high dividend yield despite plain business performance
    Baiyunshan serves up high dividend in lieu of vanilla results
    0874.HK
    600332.SHG
  2. BRIEF: Yunfeng invests $44 million for 10,000 ether tokens
    0376.HK
  3. BRIEF: Innogen launches $87 million Hong Kong IPO
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva